Physician profile

Cheyenne M Gasaway

Family · Wilmington, OH

NPI 1881133106

$3,311.33

in general payments reported to CMS, 2019-2025

31 companies · $619 in 2025

The $619 reported for 2025 was more than what 78% of Family providers received nationally (typical 2025 total: $167).

See the full distribution for Family

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$2,135.84

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $800.47 2021-2025
Novo Nordisk INC $676.46 2021-2025 Ozempic, Rybelsus, Wegovy
Lilly USA, LLC $386.62 2021-2025 Mounjaro, Zepbound, Jardiance
Dexcom, INC. $252.22 2023-2025 Dexcom G6 Transmitter
Astrazeneca Pharmaceuticals LP $232.17 2022-2025 Farxiga, Airsupra, Breztri
Abbott Laboratories $138.54 2022-2024 Freestyle Libre 3
Boehringer Ingelheim Pharmaceuticals, INC. $78.24 2021-2025 Jardiance
Bayer Healthcare Pharmaceuticals INC. $63.97 2024-2025
Novartis Pharmaceuticals Corporation $63.26 2022-2024
Tandem Diabetes Care, INC. $62.87 2025 T:Slim X2 Insulin Pump With Control-Iq
Glaxosmithkline, LLC. $61.07 2022-2023 Trelegy Ellipta, Shingrix, Arexvy
Insulet Corporation $51.82 2024 Omnipod
Beta Bionics, INC. $49.73 2025 Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $41.46 2021-2022
Amgen INC. $40.18 2021-2024 Repatha, Otezla
Show all 31 companies
CompanyGeneral paymentsYearsTop products
Mannkind Corporation $31.86 2023 Afrezza
Otsuka America Pharmaceutical, INC. $30.96 2022-2024 Rexulti
Pfizer INC. $30.55 2023-2024
Takeda Pharmaceuticals U.S.A., INC. $30.14 2021-2023 Trintellix
Corcept Therapeutics $22.31 2025 Korlym
Medtronic, INC. $19.64 2025 Minimed 780g
Antares Pharma, INC. $18.61 2023 Tlando, Xyosted, Nocdurna
Phathom Pharmaceuticals, INC. $17.92 2024 Voquezna
Acerus Pharmaceuticals Corporation $15.01 2022
Xeris Pharmaceuticals, INC. $13.91 2025 Recorlev
Merck Sharp & Dohme LLC $13.89 2022
Currax Pharmaceuticals LLC $13.85 2024 Contrave
Biohaven Pharmaceuticals, INC. $13.79 2021
Idorsia Pharmaceuticals US INC $13.71 2023 Quviviq
Astellas Pharma US INC $13.13 2021
Biohaven Pharmaceutical Holding Company LTD. $12.97 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Cheyenne M Gasaway

$3,311.33

in general payments reported 2019-2025

Years
2021-2025
Top company
Abbvie INC.
Context
The $619 reported for 2025 was more than what 78% of Family providers received nationally (typical 2025 total: $167).

https://glasscript.com/doctor/10594821/cheyenne-m-gasaway

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.